Nexus Finance
GNOM.L Genomics & Biotechnology UCITS ETF | IE00BM8R0N95

TER

0.5%

Total Expense Ratio per year

Fund Size

$52312.91B

Assets under management

Holdings

50

Underlying equities

Dividend Yield

0.00%

Accumulating

Performance Analysis

Based on selected timeframe (1D)

Top Performers - Upside

Bristol-Myers Squibb Company BMY
+0.94%
Vertex Pharmaceuticals Incorpor VRTX
+0.90%
Praxis Precision Medicines, Inc PRAX
+0.90%

Top Performers - Downside

Vir Biotechnology, Inc. VIR
-6.96%
GeneDx Holdings Corp. WGS
-6.75%
Legend Biotech Corporation LEGN
-5.57%

Top Contributors - Upside

Vertex Pharmaceuticals Incorpor VRTX • Weight: 3.78% • Perf: +0.90%
+0.03% Impact
Praxis Precision Medicines, Inc PRAX • Weight: 3.25% • Perf: +0.90%
+0.03% Impact
BioMarin Pharmaceutical Inc. BMRN • Weight: 3.70% • Perf: +0.78%
+0.03% Impact

Top Contributors - Downside

Moderna, Inc. Weight: 4.15% • Perf: -5.17%
-0.21% Impact
Legend Biotech Corporation Weight: 3.54% • Perf: -5.57%
-0.20% Impact
10x Genomics, Inc. Weight: 4.29% • Perf: -3.72%
-0.16% Impact

ETF Profile

Provider Global X
Region World
Country N/A
Sector Health Care
Strategy N/A
Theme Biotech
Distribution Policy Accumulating
Replication Full replication
Sustainable No

Aggregate Fundamentals

Weighted average of underlying holdings

Avg P/E Ratio 35.88
Avg Forward P/E -140.16

Growth Analysis

EPS Growth (LY->CY) -1146.68%
Revenue Growth (LY->CY) +47.24%
EPS Growth (CY->NY) +91.95%
Revenue Growth (CY->NY) +536.64%
ende